Antiangiogenic therapy for portal hypertension in liver cirrhosis: Current progress and perspectives

Developing medicines for hemodynamic disorders that are characteristic of cirrhosis of the liver is a relevant problem in modern hepatology. The increase in hepatic vascular resistance to portal blood flow and subsequent hyperdynamic circulation underlie portal hypertension (PH) and promote its prog...

Descripción completa

Detalles Bibliográficos
Autores principales: Garbuzenko, Dmitry Victorovich, Arefyev, Nikolay Olegovich, Kazachkov, Evgeniy Leonidovich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2018
Materias:
Minireviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127663/
https://www.ncbi.nlm.nih.gov/pubmed/30197479
http://dx.doi.org/10.3748/wjg.v24.i33.3738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6127663/
https://www.ncbi.nlm.nih.gov/pubmed/30197479
http://dx.doi.org/10.3748/wjg.v24.i33.3738

Ejemplares similares